Name
PANCREATIN
Mode of Action
PANCREATIN HYDROLYSES FATS TO GLYCEROL AND FATTY ACIDS, BREAKS DOWN PROTEIN INTO PEPTIDES, PROTEISES AND DERIVED SUBSTANCES, AND CONVERTS STARCH INTO DEXTRINS AND SUGARS. IT IS USED BY MOUTH IN CONDITIONS OF PANCREATIC EXOCRINE DEFICIENCY.
Dosage
3000 UNITS OF PROTEASE, 60,000 UNITS OF AMYLASE, AND 56,000 UNITS OF LIPASE ACTIVITY. DOSES SHOULD NOT EXCEED 10,000 UNITS OF LIPASE ACTIVITY PER KG BODY WT. FOR CYSTIC FIBROSIS. CHILDREN NOT RECOMMENDED. (ALSO SEE LIT).
Drug Group
[ENZYME]
Cross Reaction
IT HAS DRUG INTERACTION WITH ORAL ANTACIDS & IRON SALTS CAUSING IMPAIRMENT OF ITS ACTION. IT CAN REDUCE THE EFFECT OF ACARBOSE ON CO-ADMINISTRATION.
Drug Interaction
Drugs Side Effect
Drug Categories
Special Precaution
Drug Safety
Monograph